EP2822590 - Bibliographic data
FORMULATION D'ANTICORPS IL-17
Last update | 17/07/2025 |
---|---|
Legal status | Brevet délivré |
Origin | Euro-PCT |
(73) Holder |
Société ELI LILLY AND COMPANY Lilly Corporate Center
Indianapolis, IN 46285
États-Unis d'Amérique
|
---|---|
(72) Inventors |
Vincent CORVARI c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288
États-Unis d'Amérique
Barbara WILLIAMS c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288
États-Unis d'Amérique
Patrick DONOVAN c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288
États-Unis d'Amérique
Aaron MARKHAM c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288
États-Unis d'Amérique
|
(74) Agent |
Mail recipient
OFFICE FREYLINGER SA BP 48 - 234, ROUTE D'ARLON,
8001
STRASSEN
Luxembourg
|
(21) Request number | EP13710214.1 |
---|---|
(22) Request date | 01/03/2013 |
(11) Publication number | EP2822590 |
---|---|
Publication date | 26/10/2016 |
(54) Title of the invention | FORMULATION D'ANTICORPS IL-17 |
---|---|
(51) International classification | A61K 39/395, C07K 16/24 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 201261607671 P |
---|---|
Initial application | None |
Divisional application | EP16195503.4 /EP3156073 None |
Expected annuity | Annuity: 14 - Amount: 365 € - Due date 31/03/2026 |
---|---|
Last annuity | Annuity: 13 - Payment date 28/02/2025 |
Publication | None |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 26/10/2016 Constitution de mandataire pour un dossier - Legal date 19/12/2016 |